Faga Daniel, President and CEO of AnaptysBio ($ANAB), sold about $1.7 million in company shares through three open market transactions over the past year. His most recent sale occurred on January 8, 2026. These sales rank 3,786th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Daniel made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 271100 | $0.00 | 271,100.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Restricted Stock Unit | 100200 | $0.00 | 100,200.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 11,000.0000 | 27,688,470 | 50.00% | 0.04% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Restricted Stock Unit | 69355 | $0.00 | 69,355.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Restricted Stock Unit | 17850 | $0.00 | 17,850.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 133400 | $0.00 | 133,400.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 305500 | $0.00 | 305,500.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 379620 | $0.00 | 379,620.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 194900 | $0.00 | 194,900.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 9200 | $0.00 | 9,200.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 2321 | $0.00 | 2,321.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 11000 | $0.00 | 11,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 133400 | $0.00 | 133,400.0000 | 27,688,470 | 9999.99% | 0.48% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 133400 | $0.00 | 133,400.0000 | 27,688,470 | 50.00% | 0.48% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 305500 | $0.00 | 305,500.0000 | 27,688,470 | 9999.99% | 1.10% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 305500 | $0.00 | 305,500.0000 | 27,688,470 | 50.00% | 1.10% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 379620 | $0.00 | 379,620.0000 | 27,688,470 | 9999.99% | 1.37% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 379620 | $0.00 | 379,620.0000 | 27,688,470 | 50.00% | 1.37% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 194900 | $0.00 | 194,900.0000 | 27,688,470 | 9999.99% | 0.70% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 194900 | $0.00 | 194,900.0000 | 27,688,470 | 50.00% | 0.70% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 9200 | $0.00 | 9,200.0000 | 27,688,470 | 9999.99% | 0.03% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 9200 | $0.00 | 9,200.0000 | 27,688,470 | 50.00% | 0.03% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 2321 | $0.00 | 2,321.0000 | 27,688,470 | 9999.99% | 0.01% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 2321 | $0.00 | 2,321.0000 | 27,688,470 | 50.00% | 0.01% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Employee Stock Option (right to buy) | 11000 | $0.00 | 11,000.0000 | 27,688,470 | 9999.99% | 0.04% |
| April 20, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 16,510.0000 | 27,688,470 | 39.99% | 0.04% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Restricted Stock Unit | 98600 | $0.00 | 98,600.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | First Tracks Biotherapeutics, Inc. | $TRAX | Faga Daniel | President, CEO | A | Restricted Stock Unit | 80512 | $0.00 | 80,512.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 490 | $59.62 | 506,412.0000 | 27,688,470 | 0.10% | 0.00% |
| March 25, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Common Stock | 34300 | $0.00 | 513,644.0000 | 27,688,470 | 7.16% | 0.12% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 510 | $56.61 | 513,134.0000 | 27,688,470 | 0.10% | 0.00% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 2570 | $57.91 | 510,564.0000 | 27,688,470 | 0.50% | 0.01% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 3662 | $58.62 | 506,902.0000 | 27,688,470 | 0.72% | 0.01% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 550 | $60.63 | 505,862.0000 | 27,688,470 | 0.11% | 0.00% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 1012 | $62.15 | 504,850.0000 | 27,688,470 | 0.20% | 0.00% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 2592 | $63.35 | 502,258.0000 | 27,688,470 | 0.51% | 0.01% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 3155 | $64.19 | 499,103.0000 | 27,688,470 | 0.63% | 0.01% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 3038 | $65.20 | 496,065.0000 | 27,688,470 | 0.61% | 0.01% |
| March 27, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 100 | $65.99 | 495,965.0000 | 27,688,470 | 0.02% | 0.00% |
| Jan. 8, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 14281 | $44.71 | 479,344.0000 | 27,688,470 | 2.89% | 0.05% |
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Common Stock | 26838 | $0.00 | 493,625.0000 | 27,688,470 | 5.75% | 0.10% |
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Restricted Stock Unit | 26838 | $0.00 | 80,512.0000 | 27,688,470 | 25.00% | 0.10% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Restricted Stock Unit | 17850 | $0.00 | 17,850.0000 | 27,688,470 | 50.00% | 0.06% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Common Stock | 17850 | $0.00 | 475,989.0000 | 27,688,470 | 3.90% | 0.06% |
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 9202 | $45.11 | 466,787.0000 | 27,688,470 | 1.93% | 0.03% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Stock Option (right to buy) | 133400 | $0.00 | 133,400.0000 | 27,688,470 | 9999.99% | 0.48% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Restricted Stock Unit | 98600 | $0.00 | 98,600.0000 | 27,688,470 | 9999.99% | 0.36% |
| Jan. 5, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | S | Common Stock | 15309 | $43.26 | 458,139.0000 | 27,688,470 | 3.23% | 0.06% |
| Jan. 3, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Restricted Stock Unit | 34677 | $0.00 | 69,355.0000 | 27,688,470 | 33.33% | 0.13% |
| Jan. 3, 2026 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Common Stock | 34677 | $0.00 | 473,448.0000 | 27,688,470 | 7.90% | 0.13% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Common Stock | 17850 | $0.00 | 442,853.0000 | 0 | 4.20% | 0.00% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | F | Common Stock | 13033 | $14.60 | 425,003.0000 | 0 | 2.98% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Stock Option (right to buy) | 305500 | $0.00 | 305,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Common Stock | 34678 | $0.00 | 438,036.0000 | 0 | 8.60% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | A | Restricted Stock Unit | 107350 | $0.00 | 107,350.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Restricted Stock Unit | 17850 | $0.00 | 35,700.0000 | 0 | 33.33% | 0.00% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | M | Restricted Stock Unit | 34678 | $0.00 | 104,032.0000 | 0 | 25.00% | 0.00% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | President, CEO | F | Common Stock | 6387 | $15.30 | 436,466.0000 | 0 | 1.44% | 0.00% |
| July 22, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | A | Common Stock | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | F | Common Stock | 347441 | $21.60 | 401,646.0000 | 0 | 46.38% | 0.00% |
| March 25, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | S | Common Stock | 3000 | $21.42 | 749,087.0000 | 0 | 0.40% | 0.00% |
| March 22, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | S | Common Stock | 145940 | $22.78 | 752,087.0000 | 0 | 16.25% | 0.00% |
| Jan. 6, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | M | Common Stock | 17850 | $0.00 | 904,893.0000 | 0 | 2.01% | 0.00% |
| Jan. 6, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | M | Restricted Stock Unit | 17850 | $0.00 | 53,550.0000 | 0 | 25.00% | 0.00% |
| Jan. 8, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | S | Common Stock | 6866 | $21.81 | 898,027.0000 | 0 | 0.76% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | A | Stock Option (right to buy) | 379620 | $0.00 | 379,620.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | CEO | A | Restricted Stock Unit | 138710 | $0.00 | 138,710.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | Interim CEO | A | Restricted Stock Unit | 71400 | $0.00 | 71,400.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Faga Daniel | Interim CEO | A | Stock Option (right to buy) | 194900 | $0.00 | 194,900.0000 | 0 | 9999.99% | 0.00% |